Aurobindo Pharma gets USFDA nod for hypokalemia treatment drug

Aurobindo Pharma Friday said it has received final approval from the US health regulator to manufacture and market Potassium Chloride extended release tablets, used in the treatment of hypokalemia.

Original source: https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-gets-usfda-nod-for-hypokalemia-treatment-drug/67201943?utm_source=RSS&utm_medium=ETRSS

Related Posts